TA182: Acute coronary syndrome - prasugrel
This is a discussion on TA182: Acute coronary syndrome - prasugrel within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Acute coronary syndrome - prasugrel. It links to the published guidance and key ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA182: Acute coronary syndrome - prasugrel
The summary for the published technology appraisal on Acute coronary syndrome - prasugrel. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA47: Acute coronary syndromes - glycoprotein IIb/IIIa inhibitors (review) | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA80: Acute coronary syndromes - clopidogrel | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA182: Acute coronary syndrome - prasugrel | industry_news | Updates from the Technology Assessment Authorities | 0 | 10-27-2009 10:43 PM |
| Intensive Statin Therapy Benefits Bypass Patients With Acute Coronary Syndrome | industry_news | Other Clinical Pharmacy News | 0 | 10-23-2008 02:45 PM |
| Warfarin Safely Continued During Coronary Angiography | industry_news | Other Clinical Pharmacy News | 0 | 09-10-2008 02:16 PM |
© 2008 DrugManagementForum™ powered by |
 |